CYP2E1 and Cirrhosis: Interestingly, drug-metabolizing enzymes were differentially sensitive towards liver diseases, as evidenced by drastically reduced CYP2C19 activity in patients with mild liver disease, whereas CYP2E1 activity only decreased in decompensated cirrhosis [163].